IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10030004 B1

PDFFull Text
Date of Patent:
Jul. 24, 2018

Filed:

Dec. 31, 2014

Compounds and methods of use

Applicant:

Medivation Technologies Llc, San Francisco, CA (US);

Inventors:

Roopa Rai, San Francisco, CA (US);

Sarvajit Chakravarty, San Francisco, CA (US);

Brahmam Pujala, Noida, IN;

Bharat Uttam Shinde, Noida, IN;

Anjan Kumar Nayak, Noida, IN;

Naveen Chaklan, Noida, IN;

Anil Kumar Agarwal, Noida, IN;

Sreekanth A. Ramachandran, Noida, IN;

Son Minh Pham, San Francisco, CA (US);

Assignee:

Medivation Technologies LLC, San Francisco, CA (US);

Attorney:

Banner & Witcoff, Ltd.

Primary Examiner:

Sarah Pihonak

Int. Cl.
CPC ...
A61K 31/444 (2006.01); A61K 31/4439 (2006.01); A61K 31/4545 (2006.01); A61K 31/4709 (2006.01); A61K 31/506 (2006.01); A61K 45/06 (2006.01); C07D 213/72 (2006.01); C07D 213/73 (2006.01); C07D 213/82 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/4709 (2013.01); A61K 31/506 (2013.01); A61K 45/06 (2013.01); C07D 213/72 (2013.01); C07D 213/73 (2013.01); C07D 213/82 (2013.01); C07D 401/14 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract

This disclosure provides compounds and compositions and methods of using those compounds and compositions to treat diseases and disorders associated with excessive transforming growth factor-beta (TGFβ) activity. This disclosure also provides methods of using the compounds in combination with one or more cancer immunotherapies.

Find Patent Forward Citations

Loading…